It plays a role in promoting cellular protection, supporting liver detoxification, enhancing energy production, and boosting immune function
Collectively, these findings demonstrated that H188 expressed in HEK293 cells served as an accurate biosensor for detection of cAMP
JPMorgan researchers estimate that 30 million people may be taking GLP-1 drugs by 2030, or around 9% of the US population
NAION occurs when there is a reduction in blood flow to the optic nerve
Getting enough protein is vital to minimizing muscle loss on GLP-1s Fiber intake is important because GLP-1s slow down digestion
The headline On Thursday 21 May 2026, Eli Lilly announced that participants in TRIUMPH-1, the first Phase 3 trial of retatrutide in obesity, lost an average of 28.3% of their body weight at 80 weeks on the 12 mg dose, with 45.3% losing at least 30% of their starting weight [1]